Epithelial proliferation in the normal human breast in relation to endogenous hormones and oral contraceptive use

Breast

Volumn 7, Issue 3, 1998, Pages 162-167

  Johansson, C M ^a   Anderson, T J ^b   Bergstrom R ^a   Lindgren, A ^a   Persson, I R ^a,c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; HORMONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ARTICLE; BREAST EPITHELIUM; BREAST REDUCTION; CELL PROLIFERATION; CLINICAL ARTICLE; EPITHELIUM CELL; FEMALE; HORMONE BLOOD LEVEL; HUMAN; IMMUNOASSAY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; REGULATORY MECHANISM;

EID: 0031850067     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(98)90029-7     Document Type: Article

References (26)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347: 1713-1727.
2. Adami H O, Persson I. Hormone replacement and breast cancer. A remaining Controversy. JAMA 1995; 274: 178-179.
3. Preston-Martin S, Pike M C, Ross R K, Jones P A, Henderson H E. Increased cell division as a cause of human cancer. Cancer Res 1990; 50: 7415-7421.
4. Key T, Pike M. The role of estrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24: 29-43.
5. Clarke C L, Sutherland R L. Progestin regulation of cellular proliferation. Endocr Rev 1990; 11: 266-300.
6. Longacre T A, Bartow S A. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986; 10: 382-393.
7. Potten C S, Watson R J, Williams G T. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 1988; 58: 163-170.
8. Anderson T J, Ferguson D J P, Raab G M. Cell turnover in the 'resting' human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer 1982; 46: 376-382.
9. Söderqvist G, Isaksson E, von Schoultz B O, Carlström K, Tani E, Skoog L. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 1997, 176: 123-128.
10. Gompel A, Malet C, Spritzer P. Progestin effect on cell proliferation and 17β-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 1986; 63: 1174-1180.
11. Klevjer-Anderson P, Buehring G C. Effect of hormones on epithelia in cell culture. In Vitro 1980; 16: 491-501.
12. Colditz G A, Hankinson S E, Hunter D J et al. The use of estrogens and progestins and the risk of breast cancer in post menopausal women. N Engl J Med 1995; 332: 1589-1593.
13. Bergkvist L, Adami H O, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989; 321: 293-297.
14. McCormick D, Chong H, Hobbs C, Datta C, Hall P A. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 1993; 22: 355-360.
15. Grogan T M, Casey T T, Miller P C, Rangel C S, Nunnery D W, Nagle R B. Automation of immunohistochemistry. In: Advances in pathology and laboratory medicine, vol 6. St Louis Mosby-Year Book Inc., 1993.
16. Williams G, Anderson E, Howell A et al. Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 1991; 48: 206-210.
17. Anderson T J, Battersby S, King R J B, McPherson K, Going J J. Oral contraceptive use influences resting breast proliferation. Hum Pathol 1989; 20: 1139-1144.
18. Battersby S, Robertson B J, Anderson T J, King R J B, McPherson K. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br J Cancer 1992; 65: 601-607.
19. Battersby S, Anderson T J. Histological changes in breast tissue that charactertize recent pregnancy. Histopathology 1989; 15: 415-433.
20. King R J B. Heterogeneity of endocrine response within tissues. Ann NY Acad Sci 1990; 595: 242-250.
21. Simpson E R, Mendelson C R. The regulation of oestrogen biosynthesis in human adipose tissue. Proc R Soc Edinb 1989; 95B: 153-159.
22. Miller W R, Mullen P. Factors influencing aromatase activity with breast. J Steroid Biochem Mol Biol 1993; 44: 597-604.
23. Cline J M, Söderqvist G, Schoultz E, Skoog L. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques. Am J Obstet Gynecol 1996; 174: 93-100.
24. Laidlaw I J, Clarke R B, Howell A, Owen A W M C, Potten C S, Anderson E. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 1995; 136: 164-171.
25. King R J B. The role of oestrogen and progestins in human mammary carcinogenesis. In Goldhirsch A, ed. Endocrine therapy of breast cancer IV. Berlin: Springer Verlag 1990: 3-8.
26. Sutherland R L, Watts C K W, Musgrove E A. Cell cycle control by steroid hormones in breast cancer: implications for endocrine resistance. Endocrine Related Cancer 1995; 2: 87-96.